The efficacy of intensive granulocyte and monocyte adsorption apheresis in a patient with Crohn's disease complicated by extensive subcutaneous aseptic neutrophilic abscesses

Journal of Crohn's and Colitis

Volumn 6, Issue 7, 2012, Pages 787-791

  Kato, Shingo ^a   Hosomi, Eriko ^a   Amano, Fumi ^a   Kobayashi, Taisuke ^a   Kani, Kazuhito ^a   Yamamoto, Ryuichi ^a   Ogawa, Tomonari ^a   Matsuda, Akihiko ^a   Sato, Yoshiki ^a   Izaki, Seiichi ^a   Mitarai, Tetsuya ^a   Yakabi, Koji ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Apheresis; Aseptic abscess; Crohn's disease

Indexed keywords

C REACTIVE PROTEIN; MESALAZINE; PREDNISOLONE; TACROLIMUS;

ADSORPTION; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; GRANULOCYTE; GRANULOCYTE AND MONOCYTE ADSORPTIVE APHERESIS; HUMAN; LEUKAPHERESIS; MALE; MONOCYTE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; SKIN ABSCESS; SUBCUTANEOUS ASEPTIC NEUTROPHILIC ABSCESS; SYMPTOM; TREATMENT OUTCOME;

ABSCESS; ADULT; COLONIC DISEASES; CROHN DISEASE; EDEMA; GRANULOCYTES; HUMANS; LEUKAPHERESIS; MALE; MONOCYTES; SKIN DISEASES; YOUNG ADULT;

EID: 84863424440     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.02.005     Document Type: Article

References (19)

1. Safa G., Loppin M., Tisseau L., Lamoril J. Cutaneous aseptic neutrophilic abscesses and Yersinia enterocolitica infection in a case subsequently diagnosed as Crohn's disease. Dermatology 2008, 217:340-342.
2. André M.F., Piette J.C., Kémény J.L., Ninet J., Jego P., Delèvaux I., et al. Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature. Medicine (Baltimore) 2007, 86:145-161.
3. Saniabadi A.R., Hanai H., Fukunaga K. Sawada, Bjarnason I, Lofberg R. Therapeutic leukocytapheresis for inflammatory bowel disease (Review). Transfus Apher Sci 2007, 37:191-200.
4. Saniabadi A.R., Hanai H., Takeuchi K., Umemura K., Nakashima M., Adachi T., et al. Adacolomn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory disease associated with leukocytes. Ther Apher Dial 2003, 7:48-59.
5. Hanai H., Takeda Y., Eberhardson M., Gruber R., Saniabadi A.R., Winqvist O., et al. The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review. Clin Exp Immunol 2011, 163:50-58.
6. Ohmori T., Yamagiwa A., Nakamura I., Nishikawa K., Saniabadi A.R. Treatment of pyoderma gangrenosum associated with Crohn's disease. Am J Gastroenterol 2003, 98:2101-2102.
7. Polcz M., Gu J., Florin T. Pyoderma gangrenosum in inflammatory bowel disease: the experience at Mater Health Services' Adult Hospital 1998-2009. J Crohns Colitis 2011, 5:148-151.
8. Matsui T., Nishimura T., Matake H., Ohta T., Sakurai T., Yao T. Granulocyte apheresis for Crohn's disease: a report on seven refractory patients. Am J Gastroenterol 2003, 98:511-512.
9. Fukuda Y., Matsui T., Suzuki Y., Kanke K., Matsumoto T., Takazoe M., et al. Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study. J Gastroenterol 2004, 39:1158-1164.
10. Sands B.E., Sandborn W.J., Löfberg R. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis. Gastroenterology 2008, 135:400-409.
11. Sakuraba A., Motoya S., Watanabe K., Nishishita M., Kanke K., Matsui T., et al. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment. Am J Gastroenterol 2009, 104:2990-2995.
12. Kato S., Kani K., Takabayashi H., Yamamoto R., Ogawa T., Matsuda A., et al. Treatment of refractory Crohn's disease by intensive granulocyte and monocyte adsorption apheresis: a report on two drug refractory cases. Intern Med 2011, 50:1591-1593.
13. Yamamoto T., Umegae S., Matsumoto K. Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study. J Gastroenterol 2011, 4688:1003-1009.
14. Cabriada J.L., Domènech E., Ibargoyen N., Hernández V., Clofent J., Ginard D., et al. Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry. J Gastroenterol 2011, 23. [Epub ahead of print:PMID: 22105230]. 10.1007/s00535-011-0499-2.
15. Dignass A.U., Eriksson A., Kilander A., Pukitis A., Rhodes J.M., Vavricka S. Clinical trial: five or ten cycles of granulocyte-monocyte apheresis show equivalent efficacy and safety in ulcerative colitis. Aliment Pharmacol Ther 2010, 31:1286-1295.
16. Domènech E., Hinojosa J., Esteve-Comas M., Gomollón F., Herrera J.M., Bastida G., et al. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Granulocytapheresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study. Aliment Pharmacol Ther 2004, 20:1347-1352.
17. Bresci G., Romano A., Mazzoni A., Scatena F., Altomare E., Capria A., et al. Feasibility and safety of granulocytapheresis in Crohn's disease: a prospective cohort study. Gastroenterol Clin Biol 2010, 34:682-686.
18. Seishima M., Mizutani Y., Shibuya Y., Nagasawa C., Aoki T. Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum. Ther Apher Dial 2007, 11:177-182.
19. Brooklyn T.N., Dunnill M.G., Shetty A., Bowden J.J., Williams J.D., Griffiths C.E., et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 2006, 55:505-509.